Home 2nd International Conference and Exhibition on Dual Diagnosis

2nd International Conference and Exhibition on Dual Diagnosis

Press Release: January 25, 2017


The purpose of this email is to invite you in the upcoming 2nd International Conference and Exhibition on Dual Diagnosis that is going to held on May 18-19, 2017 in Munich, Germany

Your enriched observations and research work will add great value to the conference and multiply its appealing impact on the topics we have lined up and provide an opportunity to discuss and respond to a series of questions about Dual Diagnosis and Addiction related disorders worldwide,

Special features of Dual Diagnosis 2017

• You can earn up to 12 CME credits that is a requirement in many states for health professionals to be board-certified and maintain their license
• Our CPD Credits scheme and guidance on appraisal can help you to meet the requirements for appraisal and Revalidation
• Our conference will offer you practical experience
• Live Streaming of your presentation through our website and YouTube

• Accepted abstracts will receive a DOI provided by Cross Ref published in Supporting Journal
• Also you can avail up to 21 CPD Credits that help you to demonstrate through the collection of a single portfolio of evidence (including evidence of CPD) that you meet the required standards.
• You can introduce your new ideas and can approach with many other medical professionals
• Speaker and Abstract pages created in Google under your name will attract worldwide acknowledgment to your profile and research and it will be visible to 35K researchers across the globe

Dual Diagnosis 2017 Organising Committee includes

Jerzy Leszek
Vice Head, Department of Psychiatry
Wroclaw Medical University

Norman S. Miller
Health Advocates PLLC
Central Michigan College of Medicine

Deanna L Mulvihill Professor
TLI Foundation, USA

J T McDevitt Director
Rice University USA

Gregory Rudolf
American Board of Addiction Medicine

Mohammed Shoaib
Head of Psychopharmacology group
Newcastle University
United Kingdom

Nachum Dafny
University of Texas Health Science Center
at Houston, USA

Gholamreza Heydari
Tobacco Prevention & Control Research
Center, Iran

Mohamed Al-Garhy
Head, Chemical Dependency Unit
Sheikh Khalifa Medical City
United Arab Emirates

For more information and abstract submission visit Click Here

We believe that your precious experience, contribution and insights act as cornerstone in enlightening our audience impulse towards a scientific horizon. Your presence will benefit the scientific community at large.

Anticipating your good consideration, Please revert for any support

Best Regards
Paul Wilson
Program Director| Dual Diagnosis 2017
Ph. 702-508-5200 Ext 8034
Customer Service: +1 (800) 216 6499
E-mail: dualdiagnosis@neuroconferences.com

Notes to editors

For more information, please contact:

Visit the newsroom of: dualdiagnosis2017